Adams Street Partners LLC Icosavax, Inc. Transaction History

Adams Street Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$7.22 - $10.05 $6,498 - $9,045	-900 Reduced 0.04%	2,179,964 $16.9 Million
Q2 2023 Aug 14, 2023	SELL	$4.89 - $10.57 $194,705 - $420,865	-39,817 Reduced 1.79%	2,180,864 $21.7 Million
Q1 2023 May 15, 2023	SELL	$5.62 - $11.51 $1.43 Million - $2.93 Million	-254,918 Reduced 10.3%	2,220,681 $12.9 Million
Q4 2022 Feb 14, 2023	SELL	$2.32 - $10.97 $2.13 Million - $10.1 Million	-916,793 Reduced 27.02%	2,475,599 $19.7 Million
Q1 2022 May 16, 2022	SELL	$4.41 - $22.5 $13 - $67	-3 Reduced -0.0%	3,392,392 $23.9 Million
Q3 2021 Nov 15, 2021	BUY	$24.85 - $40.25 $84.3 Million - $137 Million	3,392,395 New	3,392,395 $90.3 Million

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Adams Street Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Adams Street Partners LLC with notifications on news.